Ocular Neuromyotonia

Update Item Information
Title Journal of Neuro-Ophthalmology, March 1998, Volume 18, Issue 1
Date 1998-03
Language eng
Format application/pdf
Type Text
Publication Type Journal Article
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah, 10 N 1900 E SLC, UT 84112-5890
Rights Management © North American Neuro-Ophthalmology Society
ARK ark:/87278/s61p1668
Setname ehsl_novel_jno
ID 224883
Reference URL https://collections.lib.utah.edu/ark:/87278/s61p1668

Page Metadata

Title Ocular Neuromyotonia
Creator Yee, RD; Purvin, VA
Affiliation Department of Ophthalmology, Indiana University School of Medicine, Indianapolis 46202, USA.
Abstract The objective of this article was to evaluate the etiologies, findings, and treatment of ocular neuromyotonia (ONM) in three case reports. The etiologies of ONM were determined by the histories, neuroradiologic tests, or biopsies. Clinical observations, videotaping, and electronic eye movement recordings documented the eye movement abnormalities. Intermittent diplopia developed several years after myelography with thorium dioxide (Thorotrast), radiation treatment for a pituitary tumor, and radiotherapy for medulloblastoma of the posterior fossa. All of the patients had intermittent, variable tropias that occurred spontaneously or were induced by eccentric gaze. One patient had a partial third nerve palsy, and another had a unilateral internuclear ophthalmoplegia (INO). ONM involved the paretic third nerve, extraocular muscles, and ipsilateral lateral rectus muscle in one patient, the paretic medial rectus muscle (INO) in one patient, a lateral rectus muscle (INO) in one patient, and a lateral rectus muscle in the last patient. Eye movement recordings were consistent with spasms of the involved muscles. Carbamazepine (Tegretol) abolished the ONM in two patients. The other patient had been taking carbamazepine for seizures and developed ONM when the dose was decreased. Increasing the dose abolished the ONM. ONM is an unusual cause of intermittent diplopia and strabismus, but its distinctive history and signs identify it easily. Damage to the peripheral cranial nerves might produce segmental demyelination, axonal hyperexcitability, and a self-perpetuating, reverberating circuit that causes spasms of the extraocular muscles.
Subject Older people; Anticonvulsants/therapeutic use; Brain Neoplasms/radiotherapy; Carbamazepine/therapeutic use; Diplopia/etiology; Electrooculography; Eye Movements; Female; Humans; Magnetic Resonance Imaging; Male; Middle Older people; Myotonia/diagnosis; Myotonia/drug therapy; Myotonia/etiology; Ocular Motility Disorders/diagnosis; Ocular Motility Disorders/drug therapy; Ocular Motility Disorders/etiology; Oculomotor Muscles/innervation; Oculomotor Muscles/radiation effects; Oculomotor Nerve/radiation effects; Oculomotor Nerve Diseases/drug therapy; Oculomotor Nerve Diseases/etiology; Ophthalmoplegia/drug therapy; Ophthalmoplegia/etiology; Radiation Injuries/etiology
OCR Text Show
Format application/pdf
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah, 10 N 1900 E SLC, UT 84112-5890
Setname ehsl_novel_jno
ID 224865
Reference URL https://collections.lib.utah.edu/ark:/87278/s61p1668/224865